Business EconomyPosted at: Jan 23 2025 6:20PM


Senores Pharma net up 142 pc to Rs 17.2 crore in Q3

New Delhi, Jan 23 (UNI) Senores Pharmaceuticals on Thursday reported 142 percent jump in net profit year-on-year at Rs 17.2 crore in the October-December quarter of FY25 (Q3FY25), as against Rs 7.1 crore in the same quarter of FY24.
Income from operations zoomed 35 percent year-on-year to Rs 106.4 crore in Q3FY25, from Rs 78.7 crore in Q3FY24, the company said in a regulatory filing.
Commenting on the results, Mr. Swapnil Shah, Managing Director, Senores Pharmaceuticals Limited said, “We are pleased to report strong performance for Q3 and the nine-month period of FY25, driven by our strategy of developing niche products for Regulated Markets and expanding our CDMO/CMO operations. At the same time, we have continued to grow our presence and product portfolio in Emerging Markets.”
In Regulated Markets, robust growth in the CDMO/CMO segment was partly offset by a softer performance in the Marketed Products segment, which was impacted by the high base of Q3FY24. The consolidation of acquired businesses has resulted in strong growth in the Emerging Markets segment for Q3FY25. Year-on-year, the Regulated Markets and Emerging Markets businesses grew by approximately 100% and over 10 times, respectively, for 9MFY25, he said.
In 9MFY25, the company launched one new product and received ANDA approval for five products in the Regulated Markets business, bringing our total ANDA approvals to 24.
Our Emerging Markets business is growing well through portfolio and footprint expansion. Our registered product portfolio in the Emerging Markets business expanded to 267 products. With a strong product portfolio, we are now realigning our go-to-market models to make our Emerging Markets operations more profitable, the company said.
We are seeing significant traction and scale-up in our CDMO/CMO segment. Currently, we manufacture 21 products in this business and expect faster growth with the addition of new products, customers, and increased wallet share from existing customers.
We remain focused on executing our business strategies across segments and are confident that healthy growth will continue in the year ahead, Shah added.
UNI SKB CS1820
Please log in to get detailed story.
Tags: #Senores Pharma net up 142 pc to Rs 17.2 crore in Q3
More News

QualiZeal–Everest whitepaper highlights AI-led quality engineering as game changer for enterprises

19 Nov 2025 | 1:06 AM

Hyderabad, Nov 18 (UNI) QualiZeal, a global leader in AI-powered modern quality engineering, in partnership with research and advisory firm Everest Group, has unveiled a landmark whitepaper titled “Reimagining Enterprise Quality: Leveraging AI-Infused Quality Engineering Platforms for Competitive Advantage.”
The report examines how rapidly evolving software ecosystems — spanning legacy systems to cloud-native and AI-driven architectures — are redefining quality assurance needs for enterprises.

see more..

India can develop its own digital model, doesn’t need to replicate Silicon Valley: Rakhee Chachra

18 Nov 2025 | 11:00 PM

New Delhi, Nov 18 (UNI) India should build its own digital model instead of trying to mirror Silicon Valley, Rakhee Chachra, global leader for telecom, media and entertainment at IBM, said at the IT & ITeS session of the 22nd Indo-US Economic Summit today here.

see more..

Escorts Kubota to set up new plant in UP

18 Nov 2025 | 9:43 PM

Chennai, Nov 18 (UNI) Farm and construction equipment major Escorts Kubota Ltd hopes to commence commercial production at its proposed plant in Uttar Pradesh in 2028-29, said a senior official.

see more..

RBI’s core objectives are price & financial stability: RBI Ex-Governor

18 Nov 2025 | 8:20 PM

Hyderabad, Nov 18 (UNI) Former Governor of Reserve Bank of India (RBI) Dr. Duvvuri Subba Rao emphasized that the RBI’s core objectives are price stability, supporting growth, employment and ensuring financial stability.

see more..

BPCL invites startups for ‘Elevate’ cohort under BPCL Ankur Fund

18 Nov 2025 | 8:13 PM

Mumbai, Nov 18 ( UNI) Bharat Petroleum Corporation Limited (BPCL), a Fortune Global 500 company, today announced the launch of the ‘Elevate’ cohort under the BPCL Ankur Fund to support startups working in the areas of Green Technology and Cybersecurity & Resilience for Energy Operations.

see more..